Clinical Trials Browser

Phase 2/3 × calcipotriene × 1 year × Clear all

NCT05381597 2025-11-28

5-Fluorouracil and Calcipotriene for Treatment of Low Grade Skin Cancer

Phase 2/3 Recruiting

Squamous Intraepithelial Lesions